Cargando…
Neural Stem Cells as a Novel Platform for Tumor-Specific Delivery of Therapeutic Antibodies
BACKGROUND: Recombinant monoclonal antibodies have emerged as important tools for cancer therapy. Despite the promise shown by antibody-based therapies, the large molecular size of antibodies limits their ability to efficiently penetrate solid tumors and precludes efficient crossing of the blood-bra...
Autores principales: | Frank, Richard T., Edmiston, Marissa, Kendall, Stephen E., Najbauer, Joseph, Cheung, Chia-Wei, Kassa, Thewodros, Metz, Marianne Z., Kim, Seung U., Glackin, Carlotta A., Wu, Anna M., Yazaki, Paul J., Aboody, Karen S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789379/ https://www.ncbi.nlm.nih.gov/pubmed/20016813 http://dx.doi.org/10.1371/journal.pone.0008314 |
Ejemplares similares
-
Concise Review: Stem Cells As an Emerging Platform for Antibody Therapy of Cancer
por: Frank, Richard T, et al.
Publicado: (2010) -
Cellular Host Responses to Gliomas
por: Najbauer, Joseph, et al.
Publicado: (2012) -
Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma Model
por: Thu, Mya S., et al.
Publicado: (2009) -
Development of a Tumor-Selective Approach to Treat Metastatic Cancer
por: Aboody, Karen S., et al.
Publicado: (2006) -
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
por: Gutova, Margarita, et al.
Publicado: (2007)